About Juniper Pharma
Juniper Pharma is a Healthcare company based in Boston (United States) founded in 1986, and was acquired by Catalent in July 2018. Specialty company developing therapeutics for womens health and a CDMO specializing in formulation development, analytical services and clinical manufacturing. Juniper Pharma has completed 1 acquisition, including Molprofiles.co.uk. The company was acqui-hired. Juniper Pharma offers products and services including OptiForm® Solution Suite, Catalent Spray Drying, and Softgel Technology. Its focus areas include Life Sciences, Women Health, Drugs and Sustainability Tech. Its legal entity is Catalent, Inc. Its competitors include Auxilium Pharmaceuticals, Agile Therapeutics and Marius Pharmaceuticals; 3 of its 3 listed competitors have raised funding.
Company details
Juniper pharma has two major divisions - one of which is engaged in developing therapies to address unmet medical needs in womens health (Proprietary Product Pipeline) and the other is Juniper Pharma Services, a CDMO specializing in advanced characterisation, IP consulting, formulation development, analytical services and clinical manufacturing. Juniper Pharmaceuticals is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in womens health ad. Crinone (progesterone gel) is its most successful product. It utilizes novel patent protected drug delivery technologies for sustained and controlled delivery of pharmaceuticals. Its second product COL-1077 uses the same BDS gel technology as CRINONE and is being developed as an acute use anesthetic for minimally invasive gynecologic procedures. Through their Pharma Services division, they offer services such as spray drying, formulation preformulation development and analytical characterisation. They can support clinical trial manufacturing needs up to phase IIb, for a range of dosage forms including Tablets Capsules Topicals DPIs. They have capabilities to handle a range of non-sterile dosage forms such as solids, liquids, semi-solids and inhaled products including controlled drug products and substances, highly potent compounds and poor water solubles.
- Investors
- Investments & Acquisitions
- Acquired byCatalent
(Jul 2018)
Products & Services of Juniper Pharma
Juniper Pharma offers a comprehensive portfolio of products and services, including OptiForm® Solution Suite, Catalent Spray Drying, and Softgel Technology.
Integrated platform for early-phase formulation and development services
Technology for improving drug solubility and absorption
Method for encapsulating pharmaceuticals in softgel forms
Apps and channels of Juniper Pharma
its YouTube channel Catalent Pharma Solutions has 7.59K subscribers and 30 videos.
Videos from Juniper Pharma
The most watched videos on Juniper Pharma's YouTube channel, Catalent Pharma Solutions (7.59K subscribers). Click a video to play it here.
More on Catalent Pharma Solutions.
Investors in Juniper Pharma
Juniper Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Catalent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CDMO offering drug and biologics development services | 2007 | catalent.com | Somerset, United States |
Investor details for Juniper Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Juniper Pharma
Juniper Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Molprofiles.co.uk.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Phase I-IIa clinical development services are provided by this CRO. | molprofiles.co.uk | United Kingdom | 1997 | Sep 2013 | $25M |
Complete acquisition details for Juniper Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Juniper Pharma
4 dated milestones of Juniper Pharma across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Juniper Pharma is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Molprofiles.co.uk.
- Exit Acquired by Catalent.
Competitors of Juniper Pharma
Juniper Pharma has 3 listed competitors in our database, 3 of them funded. They include Auxilium Pharmaceuticals, Agile Therapeutics and Marius Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| auxilium.com | 1999 | Philadelphia, United States | $43M | Developer of therapeutics and drug-device combinations for urology and sexual health | ||
| agiletherapeutics.com | 1997 | Princeton, United States | $123.06M | Therapeutics for women's healthcare are developed and offered. | ||
| mariuspharma.com | 2017 | Raleigh, United States | $11.61M | A proprietary oral testosterone replacement therapy platform is developed. |
Detailed competitors of Juniper Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Juniper Pharma (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Juniper Pharma
Complete news archive for Juniper Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Juniper Pharma
Juniper Pharma was founded in 1986.
Juniper Pharma is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Juniper pharma has two major divisions - one of which is engaged in developing therapies to address unmet medical needs in womens health (Proprietary Product Pipeline) and the other is Juniper Pharma Services, a CDMO specializing in advanced characterisation, IP consulting, formulation development, analytical services and clinical manufacturing. Juniper Pharmaceuticals is a specialty pharmaceutical company focused on developing therapeutics that address unmet medical needs in womens health ad. Crinone (progesterone gel) is its most successful product. It utilizes novel patent protected drug delivery technologies for sustained and controlled delivery of pharmaceuticals. Its second product COL-1077 uses the same BDS gel technology as CRINONE and is being developed as an acute use anesthetic for minimally invasive gynecologic procedures. Through their Pharma Services division, they offer services such as spray drying, formulation preformulation development and analytical characterisation. They can support clinical trial manufacturing needs up to phase IIb, for a range of dosage forms including Tablets Capsules Topicals DPIs. They have capabilities to handle a range of non-sterile dosage forms such as solids, liquids, semi-solids and inhaled products including controlled drug products and substances, highly potent compounds and poor water solubles.
Juniper Pharma's top competitors include Agile Therapeutics, Auxilium Pharmaceuticals and Marius Pharmaceuticals.
Juniper Pharma offers OptiForm® Solution Suite, Catalent Spray Drying, and Softgel Technology.
Juniper Pharma has made 1 acquisition, including Molprofiles.co.uk.
Juniper Pharma has 1 investor. Key investors include Catalent.
Juniper Pharma operates through Catalent, Inc.
Yes. Juniper Pharma was acquired by Catalent in July 2018.